Startseite » Forschung » Studien Finasterid » effectiveness of finasteride vs Serenoa repens
icon1.gif   effectiveness of finasteride vs Serenoa repens [Beitrag #254130] :: Di., 15 Januar 2013 13:57 Zum vorherigen Beitrag gehen
Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study.
Rossi A, Mari E, Scarno' M, Garelli V, Maxia C, Scali E, Iorio A, Carlesimo M.
Source

Department of Dermatology and Plastic Surgery, University of Rome Sapienza I School, Rome, Italy.
Abstract

The objective of this open label study is to determine the effectiveness of Serenoa repens in treating male androgenetic alopecia (AGA), by comparing its results with finasteride. For this purpose, we enrolled 100 male patients with clinically diagnosed mild to moderate AGA. One group received Serenoa repens 320 mg every day for 24 months, while the other received finasteride 1 mg every day for the same period. In order to assess the efficacy of the treatments, a score index based on the comparison of the global photos taken at the beginning (T0) and at the end (T24) of the treatment, was used. The results showed that only 38%; of patients treated with Serenoa repens had an increase in hair growth, while 68%; of those treated with finasteride noted an improvement. Moreover finasteride was more effective for more than half of the patients (33 of 50, i.e. 66%;), with level II and III alopecia. We can summarize our results by observing that Serenoa repens could lead to an improvement of androgenetic alopecia, while finasteride confirmed its efficacy. We also clinically observed, that finasteride acts in both the front area and the vertex, while Serenoa repens prevalently in the vertex. Obviously other studies will be necessary to clarify the mechanisms that cause the different responses of these two treatments.

Quelle: Pubmed.


Den Beitrag einem Moderator melden

 Eine private Nachricht an diesen Benutzer verschicken  
 
 
Gelesene Nachricht icon1.gif
Gelesene Nachricht
Gelesene Nachricht
Vorheriges Thema: 5aR-Hemmer: Metaanalyse / Review von Studien zwischen 1992-2012 bzgl. NWs
Nächstes Thema: 2 Neue Studien zum Post Finasterid Syndrom wurden gestartet
Gehe zum Forum:
  


aktuelle Zeit: Fr. Jul 19 14:27:15 MESZ 2024

Insgesamt benötigte Zeit, um die Seite zu erzeugen: 0.07786 Sekunden
Partner Hairforlife FUE EUROPE